Korean J Anesthesiol.  1998 Jan;34(1):27-38. 10.4097/kjae.1998.34.1.27.

Mechanism of the Hypotension Produced Protamine Sulfate in Dogs

Affiliations
  • 1Department of Anesthesiology, Chonnam National University Medical School.
  • 2College of Dentistry, Chonnam National University Medical School.
  • 3Department of Anesthesiology, Seonam University Medical School, Kwangju, Korea.

Abstract

INTRODUCTION
Protamine reversal of heparin anticoagulation often produces profound hypotension. However, the precise mechanisms of its hypotensive effect have not been fully elucidated. Using a canine model, we explored the effects of cyclo-oxygenase inhibitor, indomethacin (INDO), and nitric oxide synthetase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME) either alone or both on the cardiopulmonary responses to protamine.
METHODS
Fifty-four mongrel dogs in five groups were studied during 1.5% halothane anesthesia. GroupI (n=17) received heparin (300 IU/kg iv) followed by protamine (3 mg/kg iv over 30 s) 5 min after the heparin. The same protocol were used in groups II (n=11), III (n=12), and IV (n=7), except that L-NAME (20 mg/kg), INDO (10 mg/kg), and INDO (10 mg/kg) plus L-NAME (10 mg/kg) were infused over 10 min beginning 30 min before the protamine injection, respectively. Animals in group V (n=7) were given protamine (3 mg/kg) alone. Mean arterial pressure (MAP), mean pulmonary arterial pressure (MPAP), left ventricular end-diastolic pressure (LVEDP), LVdP/dt and cardiac output and left circumflex coronary flow (LCX flow) via Doppler flowmeter and heart rate were continuously recorded in baseline conditions and up to 15 min. Plasma NOx (NO2-, NO3-) levels were also measured before (baseline) and 3, 5, 10, and 15 min after protamine injection.
RESULTS
In group I, protamine caused immediate but transient decreases of MAP (41%), cardiac index (CI, 58%), dP/dt (28%), and LVEDP (62%) and increases of MPAP (38%) and systemic and pulmonary vascular resistance indices (SVRI, 30%; PVRI, 316%). INDO significantly attenuated the hemodynamic responses to protamine, whereas L-NAME did not affect them at all. INDO plus L-NAME prevented protamine-induced hypotension, but CI (-24%) and LVEDP (-30%) showed similar changes as those in group II. Protamine increased MPAP but inconsistently, meanwhile no correlation was found between the magnitude of increase of MPAP and decrease of MAP at peak responses in groups I-IV. LCX flow increased significantly (124~188%) immediately after protamine infusion without any changes in plasma NOx levels in groups I-IV. Neither significant hemodynamic effects nor NOx release was found in animals given protamine alone.
CONCLUSION
Protamine in the presence of heparin induces profound hypotension which may be mediated by a prostanoid and other potent vasodilators. In addition, increase of PAP and NO release may not play a significant role in the protamine-induced hypotension.

Keyword

Blood, coagulation: heparin; protamine; Complication: hypotension; Pharmacology: indomethacin; nitric oxide synthase inhibitor

MeSH Terms

Anesthesia
Animals
Arterial Pressure
Cardiac Output
Dogs*
Flowmeters
Halothane
Heart Rate
Hemodynamics
Heparin
Hypotension*
Indomethacin
NG-Nitroarginine Methyl Ester
Nitric Oxide Synthase
Plasma
Prostaglandin-Endoperoxide Synthases
Protamines*
Vascular Resistance
Vasodilator Agents
Halothane
Heparin
Indomethacin
NG-Nitroarginine Methyl Ester
Nitric Oxide Synthase
Prostaglandin-Endoperoxide Synthases
Protamines
Vasodilator Agents
Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr